Pages that link to "Q39509631"
Jump to navigation
Jump to search
The following pages link to Establishment of pemetrexed-resistant non-small cell lung cancer cell lines (Q39509631):
Displaying 16 items.
- Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer (Q33572258) (← links)
- Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed. (Q34364597) (← links)
- Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer. (Q36042698) (← links)
- Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells (Q36557343) (← links)
- The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth (Q36926960) (← links)
- The antifolates (Q37183495) (← links)
- The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids. (Q37590740) (← links)
- Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer (Q38125505) (← links)
- Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells (Q39250113) (← links)
- Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling (Q39586743) (← links)
- miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells (Q41959235) (← links)
- High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase (Q47811425) (← links)
- Molecular, biological characterization and drug sensitivity of chidamide-resistant non-small cell lung cancer cells (Q48533275) (← links)
- Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer. (Q52717613) (← links)
- Mechanisms of resistance to pemetrexed in non-small cell lung cancer (Q89497165) (← links)
- The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase (Q96128346) (← links)